Differential effects of TAK-442, a novel orally active direct factor Xa inhibitor, and ximelagatran, a thrombin inhibitor, on factor V-mediated feedback on coagulation cascade and bleeding.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples